你即將離開本站

並前往https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.4101

Phase 2 study of AK104 (PD-1/CTLA-4 bispecific antibody ...

Phase 2 study of AK104 (PD-1/CTLA-4 bispecific antibody) plus lenvatinib as first-line treatment of unresectable hepatocellular carcinoma.

確定！ 回上一頁

查詢 「AK 104」的人也找了：

  1. ak-102
    2.
  2. ak-47
    3.
  3. AK 103
    4.
  4. AKM
    5.
  5. ak104康方
    6.
  6. AK 203 步槍
    7.
  7. AK-102
    8.
  8. AK-12
    9.